Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors [Phase 2]
Phase 2 clinical trial of TJ004309 in combination with atezolizumab (TECENTRIQ) for ovarian cancer and selected solid tumors has completed e…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Tarlox and Sotorasib in Patients With KRAS G12C Mutations [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Tarlox and sotorasib in KRAS G12C-mutant non-small cell lung cancer has been terminated with results pos…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic Malignancies [Phase 4]
Phase 4 master-protocol trial evaluating systemic therapies in elderly patients with thoracic malignancies, including non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Clinical Study of the Therapeutic Effectiveness of In-silico-Designed, Machine Learning Inspired, and Quantum-molecularly Coupled Personalized Neoantigenic Vaccines Microlyvaq™ in Patients With Advanced Non-small Cell Lung Cancer [EARLY_Phase 1]
Early Phase 1 update on Microlyvaq™, a personalized neoantigenic vaccine designed with in-silico, machine-learning, and quantum-molecular co…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Durvalumab and Chemotherapy Induction Followed by Durvalumab and Radiotherapy in Large Volume Stage III NSCLC [Phase 2]
Phase 2 trial evaluating induction chemotherapy with durvalumab followed by durvalumab with radiotherapy in large-volume stage III non-small…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: A Phase 1 Study of LNCB74 in Advanced Solid Tumors [Phase 1]
Status update for a Phase 1 study of the investigational agent LNCB74 in patients with various advanced solid tumors, including ovarian, bre…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 study of the antibody-drug conjugate MYTX-011 in non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Stereotactic Body Radiotherapy With Sequential Iparomlimab and Tuvonralimab (QL1706) + Chemotherapy as Neoadjuvant Therapy in Patients With Resectable Non-small-cell Lung Cancer in China (LUNG-Nanjing01): a Single-arm, Single-centre, Phase 2 Trial [Phase 2]
Phase 2, single-arm trial in China evaluating neoadjuvant stereotactic body radiotherapy with sequential iparomlimab and tuvonralimab (QL170…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating ANS014004 in combination with an EGFR-TKI for Non-Small Cell Lung Cancer with EGFR mutations. The stud…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: A Study of SHR-A1811 Combined With Adebelimumab as Neoadjuvant Therapy for Resectable HER2-Altered Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial is studying SHR-A1811 with Adebelimumab as neoadjuvant therapy for resectable HER2-altered non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors [Phase 1]
A Phase 1 study of SGN-B6A in Chinese participants with advanced solid tumors has completed, reporting safety and preliminary activity acros…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: A Phase II Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics/Pharmacodynamics of JSKN033 in Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase II clinical study evaluating safety, efficacy, and pharmacokinetics/pharmacodynamics of JSKN033 in patients with advanced non-small ce…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical Surgery [Phase 3]
Phase 3 study evaluating sunvozertinib versus placebo as adjuvant therapy in early-stage non-small cell lung cancer with EGFR exon 20 insert…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Cancer of the Lung And SeneScencE - Prospective Cohort 1 [NA]
Prospective cohort trial on non-small cell lung cancer led by Assistance Publique - Hôpitaux de Paris is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Nivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former Smokers [Phase 2]
Phase 2 trial evaluating nivolumab for reversal of squamous dysplasia in high-risk current and former smokers; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer) [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial by Hoffmann-La Roche evaluating multiple immunotherapy-based treatment combinations in metastatic non-s…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%
A real-world, first-line study (TRIMPACT) is currently recruiting to evaluate atezolizumab use in stage IV non-small cell lung cancer with P…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: A Trial of HRS-4508 Combined With Other Antitumor Therapies in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 2]
This update describes a Phase 2 clinical trial evaluating HRS-4508 in combination with other antitumor therapies for locally advanced or met…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors [Phase 3]
Phase 3 trial evaluating the duration of PD-1/PD-L1 inhibitor therapy in advanced solid tumors; the study has completed.
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma [Phase 1, Phase 2]
Clinical trial update for VMD-928 as a monotherapy and in combination with pembrolizumab to treat TrkA overexpression-driven solid tumors or…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating hippocampal avoidance in craniospinal irradiation for leptomeningeal metastases from breast cancer or no…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: A Study of MT-4561 in Patients With Various Advanced Solid Tumors [Phase 1, Phase 2]
This trial update reports that MT-4561 is being studied in multiple advanced solid tumors across Phase 1/Phase 2 and is currently recruiting…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: A Phase Ib Study of GC101 in NSCLC [Phase 1]
This document reports a Phase Ib clinical trial evaluating GC101 in non-small cell lung cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer [Phase 3]
Phase 3 clinical trial evaluating immunotherapy or targeted therapy with or without stereotactic radiosurgery for brain metastases in patien…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Neoadjuvant Sunvozertinib in Stage II-IIIB Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutation. [Phase 2]
This is a Phase 2 neoadjuvant trial of Sunvozertinib for potentially resectable EGFR exon 20 insertion non-small cell lung cancer (Stage II–…